key: cord-0271376-7hvdsel4
authors: Pagani, Isabel; Ottoboni, Linda; Podini, Paola; Ghezzi, Silvia; Brambilla, Elena; Bezukladova, Svetlana; Corti, Davide; Bianchi, Marco Emilio; Capobianchi, Maria Rosaria; Yates, Edwin A; Martino, Gianvito; Vicenzi, Elisa
title: Heparin protects human neural progenitor cells from Zika Virus-induced cell death and preserves their differentiation into mature neural-glia cells
date: 2021-05-05
journal: bioRxiv
DOI: 10.1101/2021.05.05.442746
sha: c128304a72495e9054c39648d41d30890e62ee4f
doc_id: 271376
cord_uid: 7hvdsel4

Zika virus (ZIKV) is an arbovirus member of the Flaviviridae family that causes severe congenital brain anomalies in infected fetuses. Human neural progenitor cells (hNPCs) are highly permissive to ZIKV infection, causing inhibition of cell proliferation concomitant with an induction of cell death. We previously demonstrated that pharmaceutical-grade heparin inhibited virus-induced cell death with minor effects on in vitro virus replication in ZIKV-infected hNPCs. Here we show that heparin prevented ZIKV-induced intracellular vacuoles, a signature characteristic of paraptosis, but also inhibited necrosis and apoptosis of hNPCs when grown as neurospheres (NS). Furthermore, heparin preserved the differentiation of both ZIKV-infected human-induced pluripotent stem cells (hiPSC) derived-NPCs and fetus-derived NPCs into neural-glial cells. Collectively, these results highlight the potential neuroprotective effect of heparin that could be re-purposed and exploited to drive the development of novel agents for preventing ZIKV damage.

Zika virus (ZIKV) is an arbovirus member of the Flaviviridae family that causes 25 severe congenital brain anomalies in infected fetuses. Human neural progenitor cells 26 (hNPCs) are highly permissive to ZIKV infection, causing inhibition of cell proliferation 27 concomitant with an induction of cell death. We previously demonstrated that 17, 18, 19, 20, 21, 22, 23, 24 . These findings were also reproduced in mouse animal models 

Following the strategy of repurposing drugs already approved for another 79 medical need, we described the ability of heparin to uncouple viral replication from 80 virus-induced cell death by inhibiting ZIKV cytopathic effect without affecting viral 81 replication 40 . In the present study, we have tested whether heparin can prevent ZIKV-82 induced apoptotic and non-apoptotic/paraptosis cell death in the infection of stem-cell-83 derived neural progenitors. As hiPSC-derived NPCs do not consistently recapitulate in 84 vivo embryonic human brain gene expression 41 , we employed human fetus(hf)-85 derived NPCs obtained directly from the tissue that is the main target of ZIKV infection 86 16, 23 . In addition, both hiPSC-NPCs and hf-NPCs aggregate to form 3D neurospheres (NS) when grown in non-adherent conditions and have been used as a model of in 88 vivo neurogenesis phenotype for ZIKV infection 18, 22 . We produced NS from both 89 hiPSC-NPCs and hf-NPCs to determine the effect of heparin protection on ZIKV 90 infection.

As heparin prevented virus-induced cell death with partial reduction of viral 92 replication, we tested whether in ZIKV-infected hNPCs, heparin preserved the ability 93 of hNPCs to differentiate into mature neural-glial cells. To this end, both hiPSC-NPCs 94 and hf-NPCs were infected with ZIKV and then differentiated into neuro-glial cells.

Heparin was evaluated prior to, or after, infection and was repeatedly added during 96 the differentiation experiment.

Our results highlight the potential to delay ZIKV infection and replication and 98 indicate that heparin is endowed with neuro-protective activity against the cytopathic 99 effect of ZIKV in hNPCs.

Heparin inhibits ZIKV-induced non-apoptotic cell death. We have 103 previously demonstrated that heparin prevents ZIKV-induced cells death in hNPCs 104 grown as monolayers 40 . Since a recent report highlighted a mechanism of massive 105 cytoplasmic vacuolization that leads to paraptosis-like death in ZIKV-infected HeLa 106 cells, human foreskin fibroblasts and astrocytes 33 , we tested whether vacuoles were Fig. 1C ). In contrast, heparin significantly reduced the number of 122 vacuole-positive cells to 52 out of 229 (23%). As membrane damage causes the 123 passive release of HMGB1 protein, a marker of non-apoptotic cell death, HMGB1 124 release was measured in the culture supernatant of ZIKV infected hiPSC-NPCs in the 125 presence or absence of heparin. The kinetics of HMGB1 release showed that HMGB1 was present at low levels in the cell culture supernatant of uninfected hiPSC-127 NPCs (Fig. 1D) ; however, ZIKV infection significantly increased the levels of HMGB1 128 after 6 days of infection while heparin significantly lowered HMGB1 levels to those of 129 uninfected controls (Fig. 1D) . 130 Taken together these results suggest that the ZIKV-induced cytopathic effect 131 from non-apoptotic, paraptosis-like damage was reverted by heparin treatment.

Heparin inhibits necrosis of ZIKV-infected neurospheres (NS). In order to 133 validate heparin protection of ZIKV-induced cell damage observed in hiPSC-NPCs 134 grown as a monolayer, a more complex 3D system of NS formed by NPC aggregates 135 42 was infected with ZIKV in the presence or absence of exogenous heparin. In addition 136 to hiPSC-NS, NS were obtained from hNPCs isolated from a human fetal brain (hf-137 NS). First, to determine the efficiency of ZIKV infection in hf-NPCs as compared to Fig. 2A) . Indeed, the diameter of uninfected hiPSC-NS had an 155 average size of 513±188 μm that was not statistically different from that of heparin-156 treated uninfected NS, whereas ZIKV-infected NS had a significantly smaller average 157 size (241±80 µm). Interestingly, heparin preserved the diameter of the infected NS to 158 the levels of uninfected ones (449±130 µm) (Fig. 2B) . In order to determine whether 159 the size reduction was dependent on virus-induced cell death, the extent of ZIKV- Notably, in uninfected NS, apoptosis was induced spontaneously in the core of NS as 184 described previously 43 .

As heparin prevented ZIKV-induced cytophatic effect, we tested whether the (Fig. 8A) . Astrocytes matured under all conditions although a 274 significant decrease (~15% of total cells) was observed in infected conditions 275 compared to uninfected controls (~40% of total cells); heparin partially restored glial maturation (~30% of total cells) (Fig. 8B) . 277 Similarly to hiPSC-NPCs, multiple heparin additions were tested in hf-NPCs 278 either in pre-or post-treatment conditions. As shown in Heparin treated hNPCs were protected by ZIKV-induced vacuolization, but also virus-induced apoptosis. This heparin activity was confirmed in hiPSC-NPCs and hf-NPC 308 grown either in adherence or as neurospheres. As heparin does not transverse the 309 plasma membrane, its protective mechanism must rely on molecular interactions at 310 the cellular plasma level. Heparin is known to be a potent modulator of cellular 311 receptors of growth factors such as fibroblast growth factor (FGF), epidermal growth 312 factor (EGF) and vascular endothelial growth factor (VEGF) 55 . Among the growth 313 factors involved in neurogenesis, FGF-2, together with EGF, is essential for neuronal 314 cell survival and maturation and plays a crucial role in CNS development 56 . Heparin 315 plays a critical role in the regulation of the FGF-2 activity by interacting with its receptor 316 or stabilizing it and preventing its degradation. This interaction is specific to heparin 317 and is not general to other proteoglycans 57 .

Our previous work has shown that heparin prevents ZIKV-induced cell death 319 without interfering with viral replication. In the present work, we have tested the 320 protective effect of heparin on virus-induced cell death in the NS, a 3D system formed 321 from spontaneous aggregations of hNPCs in non-adherent conditions 18 . It is well 322 established that the best 3D model for studying neurodevelopment is represented by 323 brain organoids 58 , however, their preparation from hNPCs is complex and costly. As 324 alternative to brain organoids, NS have been shown to be permissive to ZIKV infection 325 that disrupts their spherical structure by virus-induced cytopathic effects 18 . We However, we cannot exclude that heparin might also exert antiviral effects. In our previous work, hNPCs were infected at a multiplicity of infection (MOI) of 1 40 , implying 333 that on average, every cell was exposed to one virion. However, as the MOI could not Apart from differences between these two cell culture systems, the protective activity 371 of heparin against ZIKV-induced cell death is strongly preserved in all models used 372 although further investigation is needed to determine the mechanism of this protection.

Collectively, these results highlight the potential of heparin protective activity 374 against neurotropic viruses. Unfractionated heparin (UFH) as used here, is a highly 375 sulphated, high molecular weight polysaccharide with anticoagulant activity. Given its 376 high molecular weight, the proportion of UFH that can reach the fetus and protect the 377 fetal brain from virus damage is likely low. Nevertheless, heparin can be chemically 378 and enzymatically modified to obtain derivatives or fractions with low molecular weight, 

488 hiPSC-NPCs were seeded into 24-well plates at a final concentration of 100,000 cells 489 per well. Twenty-four hours post-seeding, cells were infected with the PRVABC59 490 isolate at a MOI of 0.001 and treated with heparin (100 μg/ml). Two distinct protocols 491 were adopted to test heparin effects on differentiation of hNPCs into neural-glial cells.

In the pre-treatment protocol, cells were incubated with heparin 1 h prior to infection.

After 4 h, the virus inoculum was removed and induction medium supplemented with 494 cAMP and IGF-1 was added for 1 week, followed by replacement with differentiation 495 medium for the following 3 weeks. In the post-treatment protocol, cells were infected 496 for 4 h, then virus inoculum was removed and heparin was added for 1 h. Culture medium was replaced with the induction medium supplemented with cAMP and IGF-498 1 and changed every 3 days. After 1 week, the induction medium was replaced with 499 the differentiation medium for the following 3 weeks. The differentiation medium was 500 changed every 3 days. Supernatants were harvested at different time points to 501 determine the infectious titers and cells were fixed side-by-side and cell differentiation 502 during infection with specific antibodies. Fluor-conjugated secondary antibodies were incubated for 2 hours in blocking solution 520 at room temperature, washed three times with PBS-0.1% Triton-X100. DAPI (1 µg/mL; 521 Sigma-Aldrich) in PBS was incubated for 10 minutes to counterstain the nuclei, washed three times and mounted in DAKO. NS and cells were visualized and acquired 523 using a Leica SP8 confocal microscope (Alembic Facilities). Merged images were then 524 generated using ImageJ software.

Differentiated hNPCs were fixed using 4% paraformaldehyde (PFA) for 10 min, 526 washed three times with PBS and incubated for 1 h with blocking solution PBS-0.5% 527 Triton-X100, 5% donkey serum solution. Cells were then stained with specific primary 528 antibodies, in particular, mouse anti ds-RNA ZIKA, chicken anti-neuron-specific class 529 III beta-tubulin (TuJ1, Biolegend) and anti-rabbit glial fibrillary acidic protein (GFAP, 530 Dako) overnight in blocking solution. After three washings with PBS-0.1% Triton-X100,

Alexa Fluor-conjugated secondary antibodies were incubated for 2 h in blocking 532 solution at room temperature, washed three times with PBS-0.1% Triton-X100. DAPI

(1 µg/mL; Sigma-Aldrich) in PBS was incubated for 10 minutes to counterstain the 534 nuclei, washed three times and mounted in DAKO.

The human monoclonal antibody ZKA190-rIgG1 against the Flavivirus E 536 protein was generated as previously described in 69 . The mouse monoclonal J2 Plaque Forming Assay (PFA). Vero cells (1.2x10 6 ) were seeded in 6-well 544 culture plates. 24 h later, ten-fold dilutions of virus containing supernatants were 545 prepared in culture medium supplemented with 1% heat-inactivated FBS and 1 mL of each dilution was added to the cells. The plates were incubated for 4 h at 37 °C.

Unabsorbed virus was removed and 2 ml of culture medium supplemented with 1% 548 methylcellulose (Sigma) were added to each well, followed by an incubation at 37 °C 549 for 6 days. The methylcellulose overlay was removed and the cells were stained with 550 1% crystal violet in 70% methanol. Plaques were counted and expressed as plaque- The New England journal of medicine, 

Electron microscopy specimens of hiPSC-NPCs treated, or not, with heparin (100 µg/ml) 1 h prior to infection with the PRVABC59 isolate (MOI of 1). Infected hiPSC-NPCs were fixed at 4, 6, 9, and 16 h post-infection. Increased accumulation of clusters of ZIKV particles were visible in untreated and treated infected hiPSC-NPCs; bar = 2 µm. B. Electron microscopy specimens of hiPSC-NPCs treated, or not, with heparin (100 µg/ml) 3 days post-infection. Asterisks (*) indicate vacuoles and clusters of ZIKV particles are indicated with red arrows; bar = 2 µm. C. Quantification of vacuoles in hiPSC-NPCs treated, or not, with heparin prior to infection with infected with the PRVABC59 isolate. Bars represent vacuoles-positive (red) and vacuoles-negative (blue) cells counted in more than 200 images taken from 3 independent experiments. p<0.0001 Fisher's extract test. D. Levels of HMGB1 released in the culture supernatants after 1, 3 and 6 days post-infection. Bars represent the mean ± SD of 3 independent experiments. Two-way Anova with the Bonferroni correction was used. * Represents statistical comparison among groups (****, p<0.0001). 

hf-NS were treated with heparin (100 μg/ml) 1 h prior to infection with the Brazilian 2016-INMI-1 isolate (MOI of 1). After 4 h of ZIKV adsorption, virus inoculum was removed and the medium was replenished. Bright field photomicrographs of mock-treated vs. heparin in both uninfected and infected conditions were taken 6 days post-infection. Calibration bars 150 μm. B. ZIKV caused a significant reduction in NS number and size that was reverted by heparin to the levels of control cultures. Individual NS diameter values with the mean ± SD are shown. P values were calculated by one-way Anova with the Bonferroni correction. C. Supernatant of infected hf-NS with the Brazilian 2016-INMI-1 isolate was collected 6 days post infection and tested for AK activity. The results are expressed as relative luminescent unit (RLU). Bars represent the mean ± SD of 3 independent experiments. One-way Anova was used with the Bonferroni correction. After 4 h of ZIKV adsorption, virus inoculum was removed and the medium was replenished. hiPSC-NS were fixed after 6 days post-infection. Immunostaining for dsRNA (green), vimentin (white) and cl-CASP3 (red) counterstained with DAPI (blue) in uninfected, ZIKV-infected and heparin-treated NS. Scale bar: 50 μm. Images were obtained using a SP8 confocal microscope. B. hiPSC-NS were fixed after 4 and 6 days post-infection and immunostained for cl-CASP3 antibody. Scale bar: 50 μm. Images were obtained using a SP8 confocal microscope. Z-stacks analyses were performed on 3 independent images for each condition and time points. C. Six days postinfection, infectious viral titers were determined in the supernatant by a plaque forming assay in Vero cells. Bar graphs indicate the plaque forming unit /ml (PFU/ml). Means ± SEM of 3 independent experiments are shown. P values were calculated by Student's paired t-test. hiPSC-derived NPCs were treated with heparin (100 µg/ml) before and after infection (1h) with PRVABC59 isolate (MOI 0.001). Cell cultures were maintained in induction medium for 1 week, and then differentiation medium for at least 14 days. Kinetics of viral replication were determined by titering the infectious virus released in culture supernatants by PFA in Vero cells. Graphs represent the mean ± SD of 3 independent experiments. One-way Anova was used with Bonferroni correction. * Represents the statistical comparison among groups (**, p < 0.01; ***, p<0.001). B. Differentiated hiPSC-NPCs were fixed at day 7, 12 and 14 post-infection and stained for ZIKV with envelope protein (ZIKA-green); neurons with beta tubulin III (TUJ1-white) and PAX6 (red). Blue channel is DAPI staining for all cell types. Scale bar: 75 μm and 25 μm. Images were obtained using SP8 confocal microscope. HiPSC-derived NPCs were differentiated for 2 weeks. Cells were treated with heparin either before (pre) PRVABC59 infection (MOI 0.001) or after (post) infection. Heparin was added every 3 days (black arrows). Virion release in the supernatant was quantified at different time points by a plaque forming assay in Vero cells. The graph represents the mean ± SD of 3 independent experiments. One-way Anova with Bonferroni correction was used. * Represents statistical comparison among groups (**, p < 0.01; ***, p<0.001). B. Cells were fixed after 14 days since infection and stained for ZIKV with the anti-E antibody (ZIKA-green), neurons with beta tubulin III (TUJ1-white) and PAX6 (red). Blue channel is DAPI staining for all cell types. Scale bar: 75 μm. Images were obtained using SP8 confocal microscope. Infectious virus released in supernatant was measured in a Vero-cell based Plaque Forming Assay. Cells were treated with heparin (100 µg/ml) either before (pre, 1 h) PRVABC59 infection (MOI 5) or after (post, for 4 h) infection. Cells were then differentiated for 2 weeks in a differentiation medium. The graph represents the mean ± SD of 3 independent experiments. One-way Anova with Bonferroni correction was used. * Represents statistical comparison among groups (**, p < 0.01; ***, p<0.001, ****, p<0.0001). B. Differentiated hf-NPCs were fixed at different time points; earlier time points (day 1 and 3) were stained for ZIKV with the anti-E antibody (ZIKA-green), Vimentin (white) and Pax6 (PAX6-red). Blue channel is DAPI staining for all cell types. Scale bar: 75 μm. Images were obtained using SP8 confocal microscope. C. Staining of cultures at later time points (day 7 and 14) post-infection as described in panel B. Scale bar: 75 μm. Images were obtained using a SP8 confocal microscope. 

NPCs during differentiation. A. Cells were treated with heparin (100 µg/ml) prior to and after infection (1 h) with the PRVABC59 isolate at a MOI of 5. The differentiation medium was added started 4 h post-infection. Heparin was added every 3 days up to 14 days post-infection. Infectious titers were measured in the culture supernatants by a Plaque Forming Assay in Vero cells. Nil is untreated infected cultures, pre is the treatment 1 h prior to infection; and post is the treatment 4 h post-infection. B. Cells were fixed after 7 days and stained for ZIKV with envelope protein (ZIKA-green); neurons with TUJI (white) and astrocytes with GFAP (red). Blue channel is DAPI staining for all cell types. Scale bar: 75 μm. Images were obtained using a SP8 confocal microscope.

Zika Virus

Evidence of Sexual Transmission of Zika Virus

Clinical infectious diseases : an official publication of the Infectious 599 Diseases Society of America

Guillain-Barre Syndrome outbreak associated with Zika virus infection 602 in French Polynesia: a case-control study

Evidence for Transmission of Zika Virus by Platelet Transfusion

Zika virus. II. Pathogenicity and physical properties

Genetic characterization of Zika virus strains: geographic expansion of the 611 Asian lineage

Zika virus outbreak on Yap Island, Federated States of Micronesia

Zika virus, French polynesia, South pacific

Europeen sur les maladies transmissibles

Detection and sequencing of Zika virus from amniotic fluid of fetuses with 634 microcephaly in Brazil: a case study. The Lancet Infectious diseases

Differential neuronal susceptibility and apoptosis in congenital Zika virus 640 infection

Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their 643 Growth

Zika virus impairs growth in human neurospheres and brain organoids

Zika virus infection induces mitosis abnormalities and apoptotic cell death of 649 human neural progenitor cells

Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human 652 Neuroepithelial Stem Cells and Radial Glia

Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem 656 Cells

Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through 659 Activation of the Innate Immune Receptor TLR3

Western Zika Virus in Human Fetal Neural Progenitors Persists Long Term 662 with Partial Cytopathic and Limited Immunogenic Effects

Zika-Virus-Encoded NS2A Disrupts Mammalian Cortical Neurogenesis by 665 Degrading Adherens Junction Proteins

Animal Models of Zika Virus Infection, Pathogenesis, and 668 Immunity

Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and 671 Fetal Demise

The Brazilian Zika virus strain causes birth defects in experimental models. 674

Biology of Zika Virus Infection in Human Skin Cells

Subverting the mechanisms of cell death: flavivirus manipulation of host cell 680 responses to infection

Ultrastructural Characterization of Zika Virus Replication Factories

Stress-induced unfolded protein response contributes to Zika virus-686 associated microcephaly

Zika Virus

Dorsal Root Ganglia Explants from Interferon Receptor1 Knockout Mice Causes Myelin 690 Degeneration

Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death 693 in infected cells

Identification of new 696 modulators and protein alterations in non-apoptotic programmed cell death

High mobility group box 1 released from necrotic cells enhances regrowth and 700 metastasis of cancer cells that have survived chemotherapy

Release of chromatin protein HMGB1 by necrotic cells triggers 703 inflammation

HMGB binding to DNA: single and 706 double box motifs

High mobility group protein B1 enhances DNA repair and 709 chromatin modification after DNA damage

High-712 mobility group box 1 protein orchestrates responses to tissue damage via inflammation, 713 innate and adaptive immunity, and tissue repair

Heparin prevents Zika virus induced-cytopathic effects in human neural 716 progenitor cells

A quantitative framework to evaluate modeling of cortical development by 719 neural stem cells

Human Induced Pluripotent Stem Cell-Derived 3D-Neurospheres are Suitable 722 for Neurotoxicity Screening

Imaging of neurosphere oxygenation with 725 phosphorescent probes

Coronaviridae and SARS-associated coronavirus strain HSR1

Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural 731 Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin

Distinct behaviors of neural stem and 735 progenitor cells underlie cortical neurogenesis

Neural stem cells in the adult mammalian forebrain: a relatively quiescent 738 subpopulation of subependymal cells

Precursors of neurons, neuroglia, and ependymal cells in the CNS: what 741 are they? Where are they from? How do they get where they are going?

Comparison and optimization of hiPSC 744 forebrain cortical differentiation protocols

Increased Neuronal Differentiation of Neural Progenitor Cells Derived from 747 Phosphovimentin-Deficient Mice

Zika virus infection leads to mitochondrial failure, oxidative stress and DNA 750 damage in human iPSC-derived astrocytes

Zika Virus and Birth Defects--Reviewing 753 the Evidence for Causality

Zika Virus: a re-emerging pathogen with rapidly 756 evolving public health implications

How does Zika virus cause microcephaly?

Heparin binding preference and 762 structures in the fibroblast growth factor family parallel their evolutionary diversification

Basic fibroblast growth 766 factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral 767 cortex

Heparin, but not other proteoglycans potentiates the mitogenic 770 effects of FGF-2 on mesencephalic precursor cells

Brain organoids: advances, applications and challenges

Zika virus is transmitted in neural 776 progenitor cells via cell-to-cell spread and infection is inhibited by the autophagy inducer 777 trehalose

Therapeutic Plasticity of Neural Stem Cells

Low molecular weight heparin in pregnancy: current issues

Heparin prevents programmed cell death in human trophoblast

Preimplantation and postimplantation therapy for the treatment of 789 reproductive failure

N-desulfated non-anticoagulant heparin inhibits leukocyte 792 adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and 793 reperfusion injury in vivo

The antagonism of interferon-gamma (IFN-gamma) by heparin: 796 examination of the blockade of class II MHC antigen and heat shock protein-70 expression

Heparin modulates 800 chemokines in human endometrial stromal cells by interaction with tumor necrosis factor 801 alpha and thrombin

Neural precursor cells contribute to decision-making by tuning striatal 804 connectivity via secretion of IGFBPL-1

Derivation and expansion using only small molecules of human neural 807 progenitors for neurodegenerative disease modeling

A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential